Clinical Trials Directory

Trials / Unknown

UnknownNCT00605163

A Longitudinal Observational Follow-up of the PRECEPT Study Cohort

Status
Unknown
Phase
Study type
Observational
Enrollment
530 (estimated)
Sponsor
The Parkinson Study Group · Network
Sex
All
Age
30 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to longitudinally follow consenting clinical trial participants who participated in PRECEPT (A Randomized, Double Blind, Placebo Controlled, Dose Finding Study to Assess the Efficacy and Safety of CEP 1347 in Patients With Early Parkinson's Disease). The study will assess the clinical and imaging outcomes relevant to the natural history of Parkinson's disease (PD), as well as determine early biomarkers of the disease.

Conditions

Timeline

Start date
2006-08-01
Primary completion
2010-08-01
First posted
2008-01-30
Last updated
2008-03-28

Locations

55 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT00605163. Inclusion in this directory is not an endorsement.